Home > M&A deals 2020 > Mediolanum Farmaceutici S.p.a. acquires ElsaLys Biotech SA
Add-on Acquistion · Healthcare Services · May 2020

Mediolanum Farmaceutici S.p.a. acquires ElsaLys Biotech SA

On May 7, 2020, Mediolanum Farmaceutici S.p.a. acquired ElsaLys Biotech SA, a healthcare services company in France.

Deal at a glance

AnnouncedMay 7, 2020 TypeAdd-on Acquistion TargetElsaLys Biotech SA Buyer Mediolanum Farmaceutici S.p.a. SectorHealthcare Services LocationFrance ValueNot disclosed

Target company

ElsaLys Biotech SA
France
Healthcare Servicessector
-founded
Activestatus
View the company profile →

Buyer

Mediolanum Farmaceutici S.p.a.
Company · 2 deals on record
  • 1st transaction in healthcare services
  • 1st transaction in France
2deals, all time
1in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Questions about this deal

Who acquired ElsaLys Biotech SA?Mediolanum Farmaceutici S.p.a. acquired ElsaLys Biotech SA on May 7, 2020.

What type of deal was it?It was a add-on acquistion in the healthcare services sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).